Alzheimer's disease-like neuropathology of gene-targeted APP-SLxPS1mut mice expressing the amyloid precursor protein at endogenous levels

Most transgenic mice used for preclinical evaluation of potential disease-modifying treatments of Alzheimer's disease develop major histopathological features of this disease by several-fold overexpression of the human amyloid precursor protein. We studied the phenotype of three different strai...

Full description

Bibliographic Details
Main Authors: Christoph Köhler, Ulrich Ebert, Karlheinz Baumann, Hannsjörg Schröder
Format: Article
Language:English
Published: Elsevier 2005-11-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996105001257
_version_ 1818573112760860672
author Christoph Köhler
Ulrich Ebert
Karlheinz Baumann
Hannsjörg Schröder
author_facet Christoph Köhler
Ulrich Ebert
Karlheinz Baumann
Hannsjörg Schröder
author_sort Christoph Köhler
collection DOAJ
description Most transgenic mice used for preclinical evaluation of potential disease-modifying treatments of Alzheimer's disease develop major histopathological features of this disease by several-fold overexpression of the human amyloid precursor protein. We studied the phenotype of three different strains of gene-targeted mice which express the amyloid precursor protein at endogenous levels. Only further crossing with transgenic mice overexpressing mutant human presenilin1 led to the deposition of extracellular amyloid, accompanied by the deposition of apolipoprotein E, an astrocyte and microglia reaction, and the occurrence of dilated cholinergic terminals in the cortex. Features of neurodegeneration, however, were absent. The pattern of plaque development and deposition in these mice was similar to that of amyloid precursor protein overproducing strains if crossed to presenilin1-transgenics. However, plaque development started much later and developed slowly until the age of 18 months but then increased more rapidly.
first_indexed 2024-12-15T00:06:44Z
format Article
id doaj.art-864eb377dcd34dce819a1726c992b05d
institution Directory Open Access Journal
issn 1095-953X
language English
last_indexed 2024-12-15T00:06:44Z
publishDate 2005-11-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj.art-864eb377dcd34dce819a1726c992b05d2022-12-21T22:42:42ZengElsevierNeurobiology of Disease1095-953X2005-11-01202528540Alzheimer's disease-like neuropathology of gene-targeted APP-SLxPS1mut mice expressing the amyloid precursor protein at endogenous levelsChristoph Köhler0Ulrich Ebert1Karlheinz Baumann2Hannsjörg Schröder3Institute II of Anatomy, Department of Neuroanatomy, University of Cologne, Josef Stelzmann-Straße 9, D-50931 Cologne, Germany; Corresponding author. Fax: +49 221 478 3836.Pharma Research CNS, Bayer Health Care AG, D-42096 Wuppertal, GermanyPharma Research CNS, Bayer Health Care AG, D-42096 Wuppertal, GermanyInstitute II of Anatomy, Department of Neuroanatomy, University of Cologne, Josef Stelzmann-Straße 9, D-50931 Cologne, GermanyMost transgenic mice used for preclinical evaluation of potential disease-modifying treatments of Alzheimer's disease develop major histopathological features of this disease by several-fold overexpression of the human amyloid precursor protein. We studied the phenotype of three different strains of gene-targeted mice which express the amyloid precursor protein at endogenous levels. Only further crossing with transgenic mice overexpressing mutant human presenilin1 led to the deposition of extracellular amyloid, accompanied by the deposition of apolipoprotein E, an astrocyte and microglia reaction, and the occurrence of dilated cholinergic terminals in the cortex. Features of neurodegeneration, however, were absent. The pattern of plaque development and deposition in these mice was similar to that of amyloid precursor protein overproducing strains if crossed to presenilin1-transgenics. However, plaque development started much later and developed slowly until the age of 18 months but then increased more rapidly.http://www.sciencedirect.com/science/article/pii/S0969996105001257Amyloid precursor proteinGene-targetedAmyloid depositsMicrogliaCholine acetyltransferaseApolipoprotein E
spellingShingle Christoph Köhler
Ulrich Ebert
Karlheinz Baumann
Hannsjörg Schröder
Alzheimer's disease-like neuropathology of gene-targeted APP-SLxPS1mut mice expressing the amyloid precursor protein at endogenous levels
Neurobiology of Disease
Amyloid precursor protein
Gene-targeted
Amyloid deposits
Microglia
Choline acetyltransferase
Apolipoprotein E
title Alzheimer's disease-like neuropathology of gene-targeted APP-SLxPS1mut mice expressing the amyloid precursor protein at endogenous levels
title_full Alzheimer's disease-like neuropathology of gene-targeted APP-SLxPS1mut mice expressing the amyloid precursor protein at endogenous levels
title_fullStr Alzheimer's disease-like neuropathology of gene-targeted APP-SLxPS1mut mice expressing the amyloid precursor protein at endogenous levels
title_full_unstemmed Alzheimer's disease-like neuropathology of gene-targeted APP-SLxPS1mut mice expressing the amyloid precursor protein at endogenous levels
title_short Alzheimer's disease-like neuropathology of gene-targeted APP-SLxPS1mut mice expressing the amyloid precursor protein at endogenous levels
title_sort alzheimer s disease like neuropathology of gene targeted app slxps1mut mice expressing the amyloid precursor protein at endogenous levels
topic Amyloid precursor protein
Gene-targeted
Amyloid deposits
Microglia
Choline acetyltransferase
Apolipoprotein E
url http://www.sciencedirect.com/science/article/pii/S0969996105001257
work_keys_str_mv AT christophkohler alzheimersdiseaselikeneuropathologyofgenetargetedappslxps1mutmiceexpressingtheamyloidprecursorproteinatendogenouslevels
AT ulrichebert alzheimersdiseaselikeneuropathologyofgenetargetedappslxps1mutmiceexpressingtheamyloidprecursorproteinatendogenouslevels
AT karlheinzbaumann alzheimersdiseaselikeneuropathologyofgenetargetedappslxps1mutmiceexpressingtheamyloidprecursorproteinatendogenouslevels
AT hannsjorgschroder alzheimersdiseaselikeneuropathologyofgenetargetedappslxps1mutmiceexpressingtheamyloidprecursorproteinatendogenouslevels